Allspring Global Investments Holdings LLC boosted its position in Xylem Inc. (NYSE:XYL - Free Report) by 39.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 101,554 shares of the industrial products company's stock after acquiring an additional 28,889 shares during the period. Allspring Global Investments Holdings LLC's holdings in Xylem were worth $13,304,000 at the end of the most recent quarter.
Several other hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. boosted its holdings in Xylem by 1.3% in the first quarter. Vanguard Group Inc. now owns 29,006,544 shares of the industrial products company's stock valued at $3,465,122,000 after acquiring an additional 362,127 shares during the last quarter. Swedbank AB boosted its holdings in Xylem by 13.9% in the second quarter. Swedbank AB now owns 4,366,932 shares of the industrial products company's stock valued at $564,906,000 after acquiring an additional 531,890 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Xylem by 7.3% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,024,500 shares of the industrial products company's stock valued at $480,767,000 after acquiring an additional 274,123 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in Xylem by 689.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company's stock valued at $443,074,000 after acquiring an additional 3,239,203 shares during the last quarter. Finally, Northern Trust Corp boosted its holdings in Xylem by 2.9% in the first quarter. Northern Trust Corp now owns 3,362,993 shares of the industrial products company's stock valued at $401,743,000 after acquiring an additional 94,560 shares during the last quarter. Institutional investors own 87.96% of the company's stock.
Analysts Set New Price Targets
Several equities analysts recently issued reports on XYL shares. Citigroup raised their price target on Xylem from $168.00 to $173.00 and gave the company a "buy" rating in a report on Thursday, October 9th. Cowen reissued a "hold" rating on shares of Xylem in a research note on Tuesday, August 26th. TD Cowen increased their target price on Xylem from $125.00 to $130.00 and gave the company a "hold" rating in a research note on Tuesday, August 26th. Wall Street Zen raised Xylem from a "hold" rating to a "buy" rating in a research note on Saturday, August 9th. Finally, Zacks Research raised Xylem from a "hold" rating to a "strong-buy" rating in a research note on Monday, September 22nd. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and five have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $154.67.
View Our Latest Stock Analysis on XYL
Xylem Trading Up 0.8%
NYSE XYL opened at $146.00 on Friday. The firm has a market cap of $35.54 billion, a P/E ratio of 37.92, a P/E/G ratio of 2.47 and a beta of 1.13. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.90 and a quick ratio of 1.43. The stock's 50-day moving average is $143.32 and its 200-day moving average is $131.21. Xylem Inc. has a one year low of $100.47 and a one year high of $151.16.
Xylem (NYSE:XYL - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The industrial products company reported $1.26 EPS for the quarter, topping analysts' consensus estimates of $1.15 by $0.11. The company had revenue of $2.30 billion for the quarter, compared to analyst estimates of $2.20 billion. Xylem had a return on equity of 10.33% and a net margin of 10.74%.Xylem's revenue was up 6.1% compared to the same quarter last year. During the same quarter last year, the firm posted $1.09 earnings per share. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. Sell-side analysts anticipate that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.
Xylem Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Thursday, August 28th were given a dividend of $0.40 per share. The ex-dividend date of this dividend was Thursday, August 28th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.1%. Xylem's dividend payout ratio (DPR) is currently 41.56%.
Insider Activity at Xylem
In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the firm's stock in a transaction dated Friday, September 5th. The stock was sold at an average price of $139.96, for a total transaction of $139,960.00. Following the sale, the chief accounting officer owned 2,957 shares of the company's stock, valued at $413,861.72. This trade represents a 25.27% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.27% of the stock is currently owned by corporate insiders.
About Xylem
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Featured Stories
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report